Preferred Label : oritavancin;
MeSH note : structure given in first source;
CISMeF synonym : LY 333328;
MeSH synonym : (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin;
MeSH hyponym : LY-333328; LY333328;
CISMeF hyponym : diphosphate d'oritavancine;
Is substance : O;
UNII : PUG62FRZ2E;
InChIKey : VHFGEBVPHAGQPI-LXKZPTCJSA-N;
Origin ID : C100708;
UMLS CUI : C1144403;
ATC code(s)
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3539078/fr/tenkasi-oritavancine-antibacteriens-glycopeptides
2024
false
false
false
France
vancomycin
treatment outcome
insurance, health, reimbursement
oritavancin
Product containing only oritavancin (medicinal product)
staphylococcal skin infections
staphylococcal infections
soft tissue infections
adult
Skin infection caused by Methicillin resistant Staphylococcus aureus (disorder)
infusions, intravenous
evaluation of the transparency committee
anti-bacterial agents
Lipoglycopeptides
oritavancin
---
https://www.ema.europa.eu/medicines/human/EPAR/Orbactiv
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
oritavancin
oritavancin
oritavancin
anti-bacterial agents
anti-bacterial agents
drug approval
europe
skin diseases, bacterial
soft tissue infections
adult
cellulitis
abscess
Skin Abscess
wound infection
acute disease
infusions, intravenous
Methicillin-Resistant staphylococcus aureus
staphylococcal skin infections
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
antibiotic therapy
glycopeptides
glycopeptides
---
http://www.has-sante.fr/portail/jcms/c_2581344/fr/orbactiv
2015
false
false
false
France
French
treatment outcome
oritavancin
oritavancin
oritavancin
anti-bacterial agents
anti-bacterial agents
skin diseases, bacterial
soft tissue infections
adult
cellulitis
abscess
Skin Abscess
wound infection
acute disease
infusions, intravenous
Methicillin-Resistant staphylococcus aureus
staphylococcal skin infections
aged
methicillin resistance
evaluation of the transparency committee
staphylococcal infections
antibiotic therapy
glycopeptides
glycopeptides
---